Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Martin Wisher
Advertisement
Martin Wisher, PHD, is senior director, global head of regulatory affairs for BioReliance at MilliporeSigma.
Articles by Martin Wisher
Advertisement
Latest Updated Articles
Ensuring Viral Safety of Viral Vaccines and VectorsSeptember 1st 2018
Advertisement
Advertisement